Navigation Links
Mylan Launches Generic Version of Sandostatin®
Date:4/5/2011

PITTSBURGH, April 5, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Bioniche Pharma has launched Octreotide Acetate Injection USP, pre-filled syringes (PFS), the generic version of Novartis' Sandostatin®, a treatment for a rare hormonal disorder called acromegaly. Octreotide Acetate Injection is also used to suppress or inhibit severe diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide tumors.

Mylan Institutional President Matt Erick said: "This approval is particularly important because it is the first and only PFS for this product – brand or generic – providing hospitals and clinics access to a preferred presentation that offers ease, accuracy and convenience of dosing. The addition of Octreotide Acetate Injection as Mylan Institutional's first PFS is a critical next step in expanding our already diverse portfolio of injectable products."

Octreotide Acetate Injection had U.S. sales of approximately $579 million for the 12 months ending Dec. 31, 2010, according to IMS Health. The product, which is available for immediate shipment, was developed by Chemi and is being manufactured by Italfarmaco; both companies are part of privately held Italian Pharmaceutical Group.

Bioniche Pharma is part of Mylan Institutional, a platform that provides differentiated pharmaceutical products to institutional customers throughout North America. Mylan Institutional's product offering includes the specialty injectables of Bioniche Pharma with the unit dose capabilities of Mylan's UDL Laboratories. Mylan Institutional's customers include group purchasing organizations, wholesalers, hospitals, surgical and radiology services, home infusion service providers, long-term care facilities, correctional facilities, specialty pharmacies, veterinary clinics and retail outlets.

Currently, Mylan has
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
2. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
3. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
4. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
5. Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
6. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
7. Mylan Confirms Four First-to-File Challenges
8. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
9. Mylans Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments
10. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
11. Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Mass. , May 20, 2013   Flexion ... Frederick W. Driscoll to its management ... than 30 years of financial management experience with biotechnology ... Flexion, Mr. Driscoll was chief financial officer for Novavax ... team that secured more than $250 million through a ...
(Date:5/20/2013)... 20, 2013 Recognizing exciting and ... members to its 2013 Class of Young Professors. ... will provide this outstanding international group with more ... basic science to meet global challenges.     , The ... promising young and untenured research faculty working in ...
(Date:5/20/2013)... City, CA (PRWEB) May 20, 2013 ... has announced the appointment of Lisa Baird as Executive ... on July 8, 2013. The WMIS vision ... imaging applications to understand and effectively treat diseases in ... Imaging Society (WMIS) was established in 2011 by integrating ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Dr. Sparano ... and Women’s Health at the Albert Einstein College of ... at the Montefiore Medical Center. He is also ... Center and leads the Einstein Breast Cancer Working Group, ... translational breast cancer research. He also serves as Vice ...
Breaking Biology Technology:Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3WMIS Appoints Lisa Baird as Next Executive Director 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3
... Decision Support & Knowledge ... Mobilization ... a leading,provider of diagnosis decision support software, today announced two ... and Children,s Hospitals and Clinics of Minnesota, Minneapolis and St.,Paul, ...
... US Office Relocation to California, MELBOURNE, Australia, ... appointment of Dr. Devron Averett as Chief Scientific,Advisor ... Dr. Averett will work closely with the,company,s executive ... year,to provide scientific leadership and guidance. He has ...
... leading,provider of clinical software, connectivity and information ... the founding member of the,National ePrescribing Patient ... for the United States Senate,s approval of,legislation ... adopt,electronic prescribing, or "e-prescribing," and requires adoption ...
Cached Biology Technology:Isabel Healthcare Adds Hospitals in Wisconsin & Minnesota 2Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist 2National ePrescribing Patient Safety Initiative Supports Senate's Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety 2National ePrescribing Patient Safety Initiative Supports Senate's Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety 3National ePrescribing Patient Safety Initiative Supports Senate's Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety 4
(Date:5/17/2013)... Shenzhen, China---- Why Tibetan antelope can live at ... a collaborative research published in Nature Communications ... institutes provide evidence that some genetic factors may ... highland environments. The data in this work will ... and the biology of other ruminant species. , ...
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Endocrine Society (ENDO) 95th Annual Meeting in San ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... ENDO 2013 Annual Meeting. , Awards are given ...
Breaking Biology News(10 mins):The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... Ga. From the boiling depths of undersea hydrothermal ... and the freezing cold of Antarctic glacial icemicroorganisms known ... inhospitable environments on Earth. The unique biology of these ... Can extremophiles help solve the problem of efficient and ...
... Spanish . Satellite views of the Midwestern ... billion (ppb) along the ground could reduce soybean yields by ... lost crop production, according to U.S. Department of Agriculture (USDA) ... National Aeronautics and Space Administration, Agricultural Research Service (ARS) molecular ...
... new type of laser scanning confocal microscope (LSCM) holds ... snapshot. Typical LSCMs take 3-D images of thick tissue ... layer at a time. Sometimes scientists supplement these microscopes ... of wavelengths, or "colors," in the light reflected off ...
Cached Biology News:UGA symposium explores extreme microbes’ bioenergy potential 2Monitoring ground-level ozone from space 2
Phosphate-Buffered Saline (PBS) 7.4 (1X) liquid...
...
... Rat Antibody to Human CD66 ... is expressed by human neutrophils and ... carcinoma. Clone YTH71.3 reacts with transfectants ... are CEA subfamily members(2). ...
Request Info...
Biology Products: